Polymorphism, salts, and crystallization: The relevance of solid-state development

Chimica Oggi

Volumn 24, Issue 1, 2006, Pages 41-44

  Von Raumer, Markus ^a   Dannappel, Jochen ^a   Hilfiker, Rolf ^a  

^a SOLVIAS AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33645115596     PISSN: 0392839X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (8)

1. R. Hilfiker (ed.) Polymorphism in the Pharmaceutical Industry, Wiley-VCH, Weinheim (2006)
2. W.C. McCrone, Phys. Chem. Org. Solid State, 2, pp. 725-767 (1965)
3. H.G. Brittain, Polymorphism in Pharmaceutical Solids, Marcel Decker, Inc., New York (1999)
4. S.R. Byrn et al., Solid State Chemistry of Drugs, 2nd edn., SSCI Inc. West Lafayette (1999)
5. J. Bernstein, Polymorphism in Molecular Crystals, Oxford Science Publications, Oxford (2002)
6. S. Datta, D.J.W. Grant, Nat. Rev., 3, pp. 42-57 (2004)
7. P.H. Stahl, C.G. Wermuth, (eds.), Handbook of Pharmaceutical Salts: Properties, Selection and Use, Wiley-VCH, Weinheim (2002)
8. M. von Raumer, Polymorphism, Salts and Crystallization: An Integrated Approach to Solid-State Development, Prospects 1/05, Solvias AG, Basel (2005)